Zobrazeno 1 - 10
of 955
pro vyhledávání: '"Perno CF"'
Autor:
Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 8, Pp 467-473 (2016)
Ennio Polilli,1 Valeria Cento,2 Umberto Restelli,3,4 Francesca Ceccherini-Silberstein,2 Marianna Aragri,2 Velia Chiara Di Maio,2 Antonina Sciacca,1 Fiorenzo Santoleri,5 Paolo Fazii,6 Alberto Costantini,5 Carlo Federico Perno,2 Giustino Parruti1 1Infe
Externí odkaz:
https://doaj.org/article/d40f7262b55448d28bf73be4367dce29
Autor:
de Salazar, A, Viñuela, L, Fuentes, A, Teyssou, E, Charpentier, C, Lambert-Niclot, S, Serrano-Conde, E, Pingarilho, M, Fabeni, L, De Monte, A, Stefic, K, Perno, Cf, Aguilera, A, Falces, I, Delgado, R, Fernandes, S, Diogo, I, Gomes, P, Paraskevis, D, Santoro, M, Ceccherini-Silberstein, F, Marcelin, A, Garcia, F
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
To study the prevalence of transmitted drug resistance (TDR) to INSTIs and NRTIs, and of clinically relevant resistance (CRR), in newly-diagnosed people with HIV (PWH) naïve to antiretroviral therapy (ART) in Europe.MeditRes HIV is a consortium that
Autor:
Vergni, D, Santoni, D, Bouba, Y, Lemme, S, Fabeni, L, Carioti, L, Bertoli, A, Gennari, W, Forbici, F, Perno, Cf, Gagliardini, R, Ceccherini-Silberstein, F, Santoro, M
Publikováno v:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 101
This study aimed at updating previous data on HIV-1 integrase variability, by using effective bioinformatics methods combining different statistical instruments from simple entropy and mutation rate to more specific approaches such as Hellinger dista
Autor:
Moreno, S1 smguillen@salud.madrid.org, Perno, CF2, Mallon, PW3, Behrens, G4, Corbeau, P5,6, Routy, J‐P7, Darcis, G8
Publikováno v:
HIV Medicine. Apr2019 Supplement S4, Vol. 20, p2-12. 11p.
Autor:
Vandekerckhove, LPR, Wensing, AMJ, Kaiser, R, Brun-Vézinet, F, Clotet, B, De Luca, A, Dressler, S, Garcia, F, Geretti, AM, Klimkait, T, Korn, K, Masquelier, B, Perno, CF, Schapiro, JM, Soriano, V, Sönnerborg, A, Vandamme, A-M, Verhofstede, C, Walter, H, Zazzi, M, Boucher, CAB
Publikováno v:
In The Lancet Infectious Diseases 2011 11(5):394-407
Autor:
Lazzarotto T, Chiereghin A, Piralla A, Piccirilli G, Girello A, Campanini G, Gabrielli L, Costa C, Prete A, Bonifazi F, Busca A, Cairoli R, Colombo AA, Zecca M, Sidoti F, Bianco G, Paba P, Perno CF, Cavallo R, Baldanti F, AMCLI-GLaIT working group.
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:1699-1706
Currently, no consensus has been reached on the optimal blood compartment to be used for surveillance of cytomegalovirus (CMV) and Epstein-Barr virus (EBV) DNAemia. Although several comparative studies have been performed correlating CMV and EBV DNA
Autor:
Rossotti R, Travi G, Ughi N, Corradin M, Baiguera C, Fumagalli R, Bottiroli M, Mondino M, Merli M, Bellone A, Basile A, Ruggeri R, Colombo F, Moreno M, Pastori S, Perno CF, Tarsia P, Epis OM, Puoti M, Niguarda COVID-19 Working Group.
Publikováno v:
The Journal of Infection
Journal of Infection
Journal of Infection
Highlights • Cytokine release syndrome seems to play a pivotal role in COVID-19 pathogenesis. • Tocilizumab is one of the most promising drugs for COVID-19. • Tocilizumab halved the mortality in critical patients compared to standard of care.
Autor:
Alkhatib M, Di Maio VC, De Murtas V, Polilli E, Milana M, Teti E, Fiorentino G, Calvaruso V, Barbaliscia S, Bertoli A, Scutari R, Carioti L, Cento V, Santoro MM, Orro A, Maida I, Lenci I, Sarmati L, Craxi A, Pasquazzi C, Parruti G, Babudieri S, Milanesi L, Andreoni M, Angelico M, Perno CF, Ceccherini-Silberstein F, Svicher V, Salpini R, On Behalf Of Hirma Hepatocarcinoma Innovative Research MArkers And Fondazione Vironet C Hcv Virology Italian Resistance.
Publikováno v:
Viruses
Volume 13
Issue 5
Viruses, Vol 13, Iss 743, p 743 (2021)
Volume 13
Issue 5
Viruses, Vol 13, Iss 743, p 743 (2021)
HCV is an important cause of hepatocellular carcinoma (HCC). HCV NS5A domain-1 interacts with cellular proteins inducing pro-oncogenic pathways. Thus, we explore genetic variations in NS5A domain-1 and their association with HCC, by analyzing 188 NS5
Autor:
Squillace, Nicola, Lorenzini, Patrizia, Lapadula, Giuseppe, Bandera, Alessandra, Cozzi Lepri, Alessandro, Rusconi, Stefano, Puoti, Massimo, Castagna, Antonella, Antinori, Andrea, Gori, Andrea, D'arminio Monforte, Antonella, Moroni M, Andreoni M, Angarano G, Antinori A, D'arminio Monforte A, Castelli F, Cauda R, Di Perri G, Galli M, Iardino R, Ippolito G, Lazzarin A, Perno Cf, Von Schloesser F, Viale P, Castagna A, Ceccherini-silberstein F, Cozzi-lepri A, Girardi E, Lo Caputo S, Mussini C, Puoti M, Ammassari A, Balotta C, Bonfanti P, Bonora S, Borderi M, Capobianchi Mr, Cingolani A, Cinque P, De Luca A, Di Biagio A, Gianotti N, Gori A, Guaraldi G, Lapadula G, Lichtner M, Madeddu G, Maggiolo F, Marchetti G, Marcotullio S, Monno L, Quiros Roldan E, Rusconi S, Saracino A, Cicconi P, Fanti I, Galli L, Lorenzini P, Rodano A, Shanyinda M, Tavelli A, Giacometti A, Costantini A, Mazzoccato S, Santoro C, Suardi C, Vanino E, Verucchi G, Minardi C, Quirino T, Abeli C, Manconi Pe, Piano P, Vecchiet J, Falasca K, Sighinolfi L, Segala D, Mazzotta F, Cassola G, Viscoli C, Alessandrini A, Piscopo R, Mazzarello G, Mastroianni C, Belvisi V, Caramma I, Chiodera A, Castelli Ap, Rizzardini G, Ridolfo Al, Piolini R, Salpietro S, Carenzi L, Moioli Mc, Tincati C, Puzzolante C, Abrescia N, Chirianni A, Borgia G, Guida Mg, Gargiulo M, Gentile I, Orlando R, Baldelli F, Francisci D, Parruti G, Ursini T, Magnani G, Ursitti Ma, Vullo V, D'avino A, Gallo L, Nicastri E, Acinapura R, Capozzi M, Libertone R, Tebano G, Zaccarelli M, Viviani F, Sasset L, Mura Ms, Rossetti B, Caramello P, Orofino Gc, Sciandra M, Bassetti M, Londero A, Pellizzer G, Manfrin V.
Publikováno v:
Europe PubMed Central
Objectives Our primary aim was to study diabetes mellitus (DM) arising during combination ART (cART) and to attempt to identify associations between these cases and triglycerides (TRG) and the TRG to HDL-cholesterol (TRG/HDL) ratio. Our secondary aim